Indian laboratory analytical instruments market worth $762.5 mn

According to the study, government institutions and research laboratories continue to be key customers for the analytical instrument vendors in the country


An analysis of the Indian laboratory analytical instruments market, by Frost and Sullivan has shown that the demand for customized instrumentation from end-user segments such as the pharmaceutical and drug delivery sectors is driving the laboratory analytical instruments market in India. Regulations mandating quality assurance activities, especially in the pharmaceutical sector, further accelerate the market's growth.

The study has estimated market earned revenues of more than $762.5 million in 2012 and estimates this to reach $2,370.0 million in 2018. The end-user segments covered in this research include pharmaceuticals and life sciences, government and academic research institutions, environmental safety, agricultural analytic research, third-party and food and beverage testing laboratories, and chemicals and petrochemicals.

The research adds that government funding serves as the fulcrum for laboratory analytical instrument procurement in India; government institutions and research laboratories continue to be key customers for analytical instrument vendors. The untapped agricultural and contract research end-user groups offer added scope for laboratory analytical instrument manufacturers, and the agricultural sector's shift towards application-specific instrumentation in particular, will aid the market's steady year-on-year growth.

"The increase in the number of contract research organizations in India, especially in clinical research management has led to achieve several contracts for manufacturing and research from other countries," said the analyst, Frost & Sullivan. Technological advancements in instrumentation, the creation and up-gradation of corresponding software platforms, and Research and Development (R&D) will propel the market further. Acquisitions and partnerships, which enable companies to enter niche segments and resist competition, will in turn, require technology developments and R&D, and open additional avenues for revenue generation.

However, R&D costs are high and the inability of domestic small and medium enterprises, original equipment manufacturers, and distributors to meet these expenses, restrains market development. In addition, slow implementation of government laws and regulations in several consumer segments also dampen adoption process across different segments in this market.


Previous 1 Next

Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box


GST: Boon or Bane for Healthcare?

Send this article by email